These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: the horizons-AMI CMRI substudy. Wöhrle J; Merkle N; Kunze M; Cristea E; Mehran R; Rottbauer W; Stone GW Catheter Cardiovasc Interv; 2012 Jun; 79(7):1083-9. PubMed ID: 22162175 [TBL] [Abstract][Full Text] [Related]
6. Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial. Witzenbichler B; Mehran R; Guagliumi G; Dudek D; Huber K; Kornowski R; Stuckey TD; Fahy M; Parise H; Stone GW JACC Cardiovasc Interv; 2011 Jul; 4(7):760-8. PubMed ID: 21777884 [TBL] [Abstract][Full Text] [Related]
7. Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. Dangas G; Mehran R; Guagliumi G; Caixeta A; Witzenbichler B; Aoki J; Peruga JZ; Brodie BR; Dudek D; Kornowski R; Rabbani LE; Parise H; Stone GW; J Am Coll Cardiol; 2009 Oct; 54(15):1438-46. PubMed ID: 19796737 [TBL] [Abstract][Full Text] [Related]
8. Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction: 1-year results from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial. Parodi G; Antoniucci D; Nikolsky E; Witzenbichler B; Guagliumi G; Peruga JZ; Stuckey T; Dudek D; Kornowski R; Hartmann F; Lansky AJ; Mehran R; Stone GW JACC Cardiovasc Interv; 2010 Aug; 3(8):796-802. PubMed ID: 20723849 [TBL] [Abstract][Full Text] [Related]
9. Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial). Tsujita K; Nikolsky E; Lansky AJ; Dangas G; Fahy M; Brodie BR; Dudek D; Möckel M; Ochala A; Mehran R; Stone GW Am J Cardiol; 2010 May; 105(10):1385-94. PubMed ID: 20451683 [TBL] [Abstract][Full Text] [Related]
10. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Stone GW; White HD; Ohman EM; Bertrand ME; Lincoff AM; McLaurin BT; Cox DA; Pocock SJ; Ware JH; Feit F; Colombo A; Manoukian SV; Lansky AJ; Mehran R; Moses JW; Lancet; 2007 Mar; 369(9565):907-19. PubMed ID: 17368152 [TBL] [Abstract][Full Text] [Related]
12. What anti-thrombotic therapy is best with primary PCI for acute ST elevation myocardial infarction: how should the HORIZONS trial change current practice? Brodie BR Catheter Cardiovasc Interv; 2008 May; 71(6):816-21. PubMed ID: 18412079 [TBL] [Abstract][Full Text] [Related]
13. The quality of antiplatelet and anticoagulant medication administration among ST-segment elevation myocardial infarction patients transferred for primary percutaneous coronary intervention. Wang TY; Magid DJ; Ting HH; Li S; Alexander KP; Roe MT; Peterson ED Am Heart J; 2014 Jun; 167(6):833-9. PubMed ID: 24890532 [TBL] [Abstract][Full Text] [Related]
14. Economic impact of switching to bivalirudin for a primary percutaneous coronary intervention in a US hospital. Olchanski N; Slawsky KA; Plent S; Kado C; Cyr PL Hosp Pract (1995); 2010 Nov; 38(4):138-46. PubMed ID: 21068538 [TBL] [Abstract][Full Text] [Related]
15. Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial). Lansky AJ; Mehran R; Cristea E; Parise H; Feit F; Ohman EM; White HD; Alexander KP; Bertrand ME; Desmet W; Hamon M; Stone GW Am J Cardiol; 2009 May; 103(9):1196-203. PubMed ID: 19406258 [TBL] [Abstract][Full Text] [Related]